Poesen Ruben, Evenepoel Pieter, de Loor Henriette, Kuypers Dirk, Augustijns Patrick, Meijers Björn
Department of Microbiology and Immunology, Division of Nephrology, University Hospitals Leuven, Leuven, Belgium; and.
Department of Pharmaceutical and Pharmacological Sciences, Drug Delivery and Disposition, University of Leuven, Leuven, Belgium.
Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1136-1144. doi: 10.2215/CJN.00160116. Epub 2016 Apr 15.
Colonic microbial metabolism substantially contributes to uremic retention solutes in CKD. p-Cresyl sulfate is the main representative of this group of solutes, relating to adverse outcomes. Other than sulfate conjugation, p-cresol is subjected to endogenous glucuronide conjugation. Whether the balance between sulfate and glucuronide conjugation is relevant in CKD is unexplored.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We prospectively followed 488 patients with CKD stages 1-5 (enrollment between November of 2005 and September of 2006; follow-up until December of 2010). Serum and urine levels of p-cresyl sulfate and p-cresyl glucuronide were measured using liquid chromatography-mass spectrometry. Total amount of microbial p-cresol was calculated by the sum of serum p-cresyl sulfate and p-cresyl glucuronide. Outcome analysis was performed for mortality and cardiovascular disease.
Serum p-cresyl sulfate was a median of 193.0-fold (interquartile range, 121.1-296.6) higher than serum p-cresyl glucuronide, with a significant correlation between eGFR and proportion of serum p-cresyl sulfate to glucuronide (rho=0.23; P=0.001). There was also a significant correlation between eGFR and proportion of 24-hour urinary excretion of p-cresyl sulfate to glucuronide (rho=0.32; P<0.001). Higher serum p-cresol and lower proportion of serum p-cresyl sulfate to glucuronide were jointly and significantly associated with mortality (hazard ratio per SD higher, 1.58; 95% confidence interval, 1.10 to 2.29; P=0.01 and hazard ratio, 0.65; 95% confidence interval, 0.47 to 0.89; P<0.01, respectively) and cardiovascular disease (hazard ratio, 1.68; 95% confidence interval, 1.27 to 2.22; P<0.001 and hazard ratio, 0.55; 95% confidence interval, 0.42 to 0.72; P<0.001, respectively) after adjustment for eGFR, Framingham risk factors, mineral bone metabolism markers, C-reactive protein, and albumin.
p-Cresol shows a preponderance of sulfate conjugation, although a relatively diminished sulfotransferase activity can be suggested in patients with advanced CKD. Along with total p-cresol burden, a relative shift from sulfate to glucuronide conjugation is independently associated with mortality and cardiovascular disease, warranting increased focus to the dynamic interplay between microbial and endogenous metabolism.
结肠微生物代谢在很大程度上导致了慢性肾脏病(CKD)患者体内尿毒症潴留溶质的产生。对甲酚硫酸酯是这类溶质的主要代表,与不良预后相关。除了硫酸结合反应外,对甲酚还会发生内源性葡萄糖醛酸结合反应。硫酸结合与葡萄糖醛酸结合之间的平衡在CKD中是否具有相关性尚不清楚。
设计、研究地点、参与者及测量方法:我们对488例1 - 5期CKD患者进行了前瞻性随访(2005年11月至2006年9月入组;随访至2010年12月)。采用液相色谱 - 质谱法测量血清和尿液中对甲酚硫酸酯和对甲酚葡萄糖醛酸酯的水平。微生物对甲酚的总量通过血清对甲酚硫酸酯和对甲酚葡萄糖醛酸酯的总和计算得出。对死亡率和心血管疾病进行了结局分析。
血清对甲酚硫酸酯的中位数比对甲酚葡萄糖醛酸酯高193.0倍(四分位间距为121.1 - 296.6),估算肾小球滤过率(eGFR)与血清对甲酚硫酸酯与葡萄糖醛酸酯的比例之间存在显著相关性(rho = 0.23;P = 0.001)。eGFR与24小时尿中对甲酚硫酸酯与葡萄糖醛酸酯的排泄比例之间也存在显著相关性(rho = 0.32;P < 0.001)。较高的血清对甲酚水平和较低的血清对甲酚硫酸酯与葡萄糖醛酸酯比例与死亡率(每标准差升高的风险比为1.58;95%置信区间为1.10至2.29;P = 0.01,风险比为0.65;95%置信区间为0.47至0.89;P < 0.01)和心血管疾病(风险比为1.68;95%置信区间为1.27至2.22;P < 0.001,风险比为0.55;95%置信区间为0.42至0.72;P < 0.001)显著相关,在对eGFR、弗雷明汉风险因素、矿物质骨代谢标志物、C反应蛋白和白蛋白进行校正后。
对甲酚主要发生硫酸结合反应,尽管在晚期CKD患者中可能提示硫酸转移酶活性相对降低。除了总的对甲酚负荷外,硫酸结合向葡萄糖醛酸结合的相对转变与死亡率和心血管疾病独立相关,这使得有必要更加关注微生物代谢与内源性代谢之间的动态相互作用。